NYSE: MDVModiv Industrial Inc Stock
$15.56+0.26 (+1.7%)
Updated Apr 21, 2025
MDV Price
$15.56
Fair Value Price
N/A
Market Cap
$155.08M
52 Week Low
$13.62
52 Week High
$18.11
P/E
62.24x
P/B
0.82x
P/S
2.96x
PEG
0.49x
Dividend Yield
4.48%
Revenue
$46.76M
Earnings
$6.02M
Gross Margin
92.3%
Operating Margin
47.56%
Profit Margin
5%
Debt to Equity
1.55
Operating Cash Flow
$18M
Beta
0.32
Next Earnings
N/A
Ex-Dividend
Mar 31, 2025
Next Dividend
Apr 25, 2025
MDV Overview
ModivCare Incorporated (formerly The Providence Service Corp.) provides healthcare services including non-emergency medical transportation, personal and home care, NEMT, and nutritional meal delivery. It places of home health aides, nurses, and non-medical personal care assistants. It also owns noncontrolling interest in Matrix Medical Network which provides in-home care optimization and care management solutions. ModivCare was founded in 1996 and is headquartered in Denver, CO.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MDV's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Diversified REIT
Industry Rating
F
MDV
Ranked#4 of 17
Ranked#4 of 17
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $24.12 | C | |
| $14.11 | C | |
| $18.77 | C |
Be the first to know about important MDV news, forecast changes, insider trades & much more!
MDV News
Overview
Due Diligence Score
–
Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MDV scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MDV ($15.56) is trading above its intrinsic value of $12.25, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MDV is poor value based on its earnings relative to its share price (62.24x), compared to the US market average (27.14x)
P/E vs Market Valuation
MDV is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MDV due diligence checks available for Premium users.
Valuation
MDV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
62.24x
Industry
16.85x
Market
27.14x
MDV is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MDV is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
MDV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.82x
Industry
1.22x
MDV is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MDV price to earnings growth (PEG)
For valuing profitable companies with growth potential
MDV is good value based... subscribe to Premium to read more.
PEG Value Valuation
MDV's financial health
Profit margin
Revenue
$11.7M
Net Income
$1.6M
Profit Margin
5.4%
MDV's Earnings (EBIT) of $22.24M... subscribe to Premium to read more.
Interest Coverage Financials
MDV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$507.8M
Liabilities
$293.8M
Debt to equity
1.55
MDV's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MDV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$5.4M
Investing
-$1.5M
Financing
$785.7k
MDV's operating cash flow ($18.24M)... subscribe to Premium to read more.
Debt Coverage Financials
MDV vs Diversified REIT Stocks
Modiv Industrial Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.